Four Federal Efforts to Monitor, Including RESULTS Act Progress
Other proposals aim to increase fraud enforcement, temper prior authorization, and modernize CLIA
Already a member? Log in here
Reimbursement-nir
Subscribe today for access to
Articles and Reports
FDA Watch: New RAPID Coverage Pathway Would Enable Some Lab Tests to Pursue Clearance and Medicare Coverage Simultaneously
FDA-CMS collaboration aims to accelerate Medicare coverage determinations of certain medical devices
Already a member? Log in here
RCM Strategies to Explore for Genetic Testing Compliance
Expert Ashley Zarling details nuances for clinical lab directors and compliance teams
Already a member? Log in here
Correction: PAMA Relief—CMS 1450 14x TOB Labs DO Count!
...
Already a member? Log in here
MACRA: QPP Year 1 By the Numbers
...
Already a member? Log in here
PAMA: ACLA Loses Court Lab Fees Battle But May Still Win Regulatory War
...
Already a member? Log in here
AAB and NILA comments allege unlawful implementation of PAMA by CMS
From – National Intelligence Report
The National Independent Laboratory Association (NILA) and the American Association of Bioanalysts (AAB) has formally commented to the…
Already a member? Log in here
Proposed 2019 OPPS Rule Includes Site-Neutral Payment, Other Changes
...
Already a member? Log in here
Medicare Reimbursement: CMS Begins Implementing New HOPPS Date of Service Rules for ADLTs & Molecular Pathology Tests
From – National Intelligence Report
CMS has begun implementing the new rules that exempt advanced diagnostic laboratory tests (ADLTs) and molecular pathology tests from…
Already a member? Log in here
PAMA Unlocks Golden Age for Innovative Diagnostics
By Chance Scott bio
The publication of the 2018 Clinical Laboratory Fee Schedule (CLFS) in January saw a long and heated debate within the lab community come to fruition…
How PAMA’s Effect in 2018 Molecular Diagnostic Reimbursement Will Make Labs More Money
By Sean McSweeney bio
The year 2018 is slated to be much brighter for molecular diagnostic labs as PAMA fee schedules show a higher payment rate and amount for many cancer genomics and…
